New Biomarker Could Help Diagnose Alzheimer’s Disease Early
American Chemical Society (ACS)Recent studies have led to the development of imaging and spinal fluid tests for patients with Alzheimer's disease. However, the tests can only monitor severe disease. Reporting in ACS Chemical Neuroscience, researchers have now identified a biomarker that could help physicians diagnose AD earlier.